Literature DB >> 31686748

Uterine Sarcoma: A Clinico-Pathological Study.

Radha Bai Prabhu Thangappah1,2,3.   

Abstract

OBJECTIVES: To analyse the clinical presentation, histological type, management, and prognosis of cases diagnosed with uterine sarcomas.
METHODOLOGY: This was a hospital-based retrospective study conducted at the Institute of Obstetrics and Gynaecology, Chennai, and Meenakshi Medical College and RI, Kancheepuram, from 2009 to 2015. Thirty patients who were diagnosed with uterine sarcoma were analysed for type of sarcoma, clinical details, treatment, and prognosis.
RESULTS: Leiomyosarcoma was the commonest type seen in ten cases followed by mixed mullerian tumours in nine cases and endometrial stromal sarcomas in six cases. Leiomyosarcomas and mixed mullerian tumours were seen between the ages of 45 and 65 years. Women with endometrial stromal tumours were younger in the age group between 35 and 45 years. Pelvic mass and pain were the predominant symptom in leiomyosarcoma and mixed mullerian tumours. Endodermal stromal tumours presented predominantly with abnormal uterine bleeding. Forty percentage of cases were diagnosed with stage I disease. Twenty-six patients were managed surgically. Post-operative adjuvant therapy was given in 12 patients. Median duration of follow-up was 52 months. During the above period, 11 were alive, eight were lost to follow-up, and 11 were dead. In those who were alive, two cases presented with local recurrences.
CONCLUSION: The pre-operative diagnosis of sarcoma is difficult and prognosis is poor even in early stage disease because of the aggressive nature of the tumours. © Federation of Obstetric & Gynecological Societies of India 2018.

Entities:  

Keywords:  Endometrial stromal sarcoma; Leiomyosarcoma; Uterine sarcoma

Year:  2018        PMID: 31686748      PMCID: PMC6801271          DOI: 10.1007/s13224-018-1141-5

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  14 in total

Review 1.  Staging of uterine sarcomas.

Authors:  Ka Yu Tse; Robin Crawford; Hextan Y S Ngan
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-07-14       Impact factor: 5.237

Review 2.  Clinical presentation and diagnosis of uterine sarcoma, including imaging.

Authors:  Tzu-I Wu; Tzu-Chen Yen; Chyong-Huey Lai
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-08-04       Impact factor: 5.237

Review 3.  Uterine sarcomas: clinical presentation and MRI features.

Authors:  Pedro Santos; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Jan-Feb       Impact factor: 2.630

4.  Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.

Authors:  Mona Hosh; Sarah Antar; Ahmed Nazzal; Mahmoud Warda; Ahmed Gibreel; Basel Refky
Journal:  Int J Gynecol Cancer       Date:  2016-07       Impact factor: 3.437

Review 5.  Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors.

Authors:  Jing-Yi Chern; Leslie R Boyd; Stephanie V Blank
Journal:  Oncology (Williston Park)       Date:  2017-03-15       Impact factor: 2.990

6.  The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma.

Authors:  Emily M Hinchcliff; Katharine M Esselen; Jaclyn C Watkins; Titilope Oduyebo; J Alejandro Rauh-Hain; Marcela G Del Carmen; Bradley J Quade; Michael G Muto
Journal:  J Minim Invasive Gynecol       Date:  2016-02-04       Impact factor: 4.137

Review 7.  Clinical management of uterine sarcomas.

Authors:  Frédéric Amant; An Coosemans; Maria Debiec-Rychter; Dirk Timmerman; Ignace Vergote
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

8.  Uterine pathology in women undergoing minimally invasive hysterectomy using morcellation.

Authors:  Jason D Wright; Ana I Tergas; William M Burke; Rosa R Cui; Cande V Ananth; Ling Chen; Dawn L Hershman
Journal:  JAMA       Date:  2014-09-24       Impact factor: 56.272

9.  The treatment of uterine sarcomas.

Authors:  P Reichardt
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

10.  Prognostic features of surgical stage I uterine carcinosarcoma.

Authors:  Sarah E Ferguson; Carmen Tornos; Amanda Hummer; Richard R Barakat; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

View more
  3 in total

1.  [Expressions of HELQ and RAD51C in endometrial stromal sarcoma and their clinical significance].

Authors:  Ying Liu; Yu Zhang; Yan Tian
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-07-30

2.  Retrospective Analysis of Patients with Gynaecological Uterine Sarcomas in a Tertiary Hospital.

Authors:  Maria Ruiz-Minaya; Elsa Mendizabal-Vicente; Wenceslao Vasquez-Jimenez; Laura Perez-Burrel; Irene Aracil-Moreno; Carolina Agra-Pujol; Mireia Bernal-Claverol; Beatriz L Martínez-Bernal; Mercedes Muñoz-Fernández; Melanie Morote-Gonzalez; Miguel A Ortega; Santiago Lizarraga-Bonelli; Juan A De Leon-Luis
Journal:  J Pers Med       Date:  2022-02-06

3.  Diagnosis and treatment of uterine sarcoma: A multicenter, real-world study in western China.

Authors:  Kemin Li; Rutie Yin; Li Li; Danqing Wang; Li Li; Cailing Ma; Qianchuan Ren; Guqing Wang; Yang Fan; Honggui Zhou; Zi Liu; Tao Li; Kunrong Luo; Dingqing Kui; Jingyi Wang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.